Business Insights, June 2010, Pages: 250
disease
Report scope
Chapter 2 Proteomics in the design of novel diagnostics for infectiousdiseases
Summary
Introduction
An overview of techniques in proteomics
Separation techniques
Two
Global Industry Analysts, Inc., Oct 2010, Pages: 659
InfectiousDiseases Testing 4
Pharmacogenomics 4
Cancer Screening 4
2. INDUSTRY OVERVIEW 5
Global Market Outlook 5
Molecular Diagnostics - The Fastest Growing Medical
Diagnostic Technology 5
Current
Datamonitor, Dec 2010, Pages: 204
major markets and its impact on commercial opportunities Overview
Catalyst
Summary
About Datamonitor healthcare
About the Infectious Disease pharmaceutical analysis team
Executive Summary
Scope of
Global Industry Analysts, Inc., Jan 2012, Pages: 173
Nervous System and Orthopedics,
InfectiousDiseases, Cardiovascular Diseases and Others 36
Transportation 37
Aerospace and Defense 37
Defying Gravity- NASA Banks on Nanotechnology 38
Nanobiotechnology
Business Insights, Jan 2010, Pages: 283
; hemostasis; cardiology; infectious disease; drugs of abuse; automated urine/blood analysis; and cancer screening.
- Surveys analytes/biomarkers incorporated in commercial POCT products on the market and in
Datamonitor, March 2008, Pages: 123
EXECUTIVE SUMMARY 3
Scope of the analysis 3
Datamonitor insight into biologics infectiousdiseases 3
Contributing experts 6
Related reports 6
Upcoming related reports 7
CHAPTER 2 COMMERCIAL OUTLOOK 9
Unmet
Business Insights, June 2007, Pages: 244
inareas such as cancer and infectiousdiseases. Since 2005, enormous strides have also been made in the development of RNAi-based therapeutic products, bringing them significantly closer to the market
Datamonitor, Aug 2010, Pages: 142
advantage by identifying key product characteristics and potential roles for new therapies
Overview
Catalyst
Summary
About Datamonitor healthcare
About the Vaccines & InfectiousDiseases pharmaceutical
GBI Research, Dec 2010, Pages: 198
therapeutics, such as oncology, infectiousdiseases including HIV, and autoimmune disorders. A strong product pipeline for most of the top 10 biotechnology companies will result in a continuation of this growth
Datamonitor, Oct 2010, Pages: 196
InfectiousDiseases Vaccine Market Overview Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid
Life Science Intelligence, Jan 2011
diagnostic assays for infectiousdiseases, with an initial focus on hospital-acquired infections
- Effective antimicrobial coatings and compounds that are broad-spectrum and fast-acting against clinically
Datamonitor, May 2010, Pages: 108
advantage by identifying key HIV players, product characteristics and potential roles for new therapies
Overview
Catalyst
Summary
Executive Summary
Scope of the analysis
Datamonitor insight into the
iCD Research, Sep 2011, Pages: 31
infectiousdiseases. It has presence in 60 countries across North America and Central America, South America, Europe, Asia, Africa, and Australia and New Zealand. Quintiles is headquartered in Durham, North
iCD Research, Feb 2012, Pages: 27
focuses principally on the fields of diabetes, pediatrics, women's health, internal medicine, cardiovascular, central nervous system, oncology, and infectiousdiseases. It has presence in 60 countries
Espicom Business Intelligence Ltd, June 2009, Pages: 472
commercial executives to get a balanced and independent overview of the competitive landscape.
That is why this major new 4-volume report, Drug Delivery Technologies: Players, Products and Prospects to 2018
GlobalData, May 2011, Pages: 50
. It offers diagnostic solutions such as instruments, reagents and software. The company's products are used in diagnosing infectiousdiseases and provide high medical value results in cancer screening
GlobalData, Aug 2011, Pages: 44
-threatening diseases. The company also focused on development of vaccine for certain infectiousdiseases, such as H1N1, herpes simplex virus disease and cancer. The company also provides products, which
